Roche signs up to $1 bln deal with Alnylam on RNAi
184065
LONDON/ZURICH  - Roche Holding AG  has signed a deal worth up to $1 billion with Alnylam Pharmaceuticals Inc. , giving it access to the U.S. firm's skills in the new science of RNA interference.
477072
MARSEILLE, FRANCE - Netino SARL sees a bright future for outsourcing in drug discovery: The 2-year-old company just landed a 10-year contract to handle the bioinformatics activities of a major French pharmaceutical company.
71950
Schering-Plough Corp  has agreed to buy Akzo Nobel NV's  drugs unit Organon BioSciences for 11 billion euros ($14.4 billion) in a bid to gain scale and diversify away from cholesterol medicine.
536259
Genzyme Corp.'s not-yet-completed $1 billion acquisition of Ilex Oncology Inc. appeared to pay off yesterday when an advisory committee to the Food and Drug Administration recommended the agency approve Ilex's experimental cancer treatment for children with certain types of leukemia.
250461
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading therapeutic RNA interference (RNAi) company, today announced the first in vivo demonstration ever published of RNAi-mediated gene silencing in mammals
551141
Boston Scientific Corp. , the struggling medical device maker, said yesterday it made a $1 billion early loan payment and renegotiated some loan agreements, giving the Natick company more breathing room as it revamps its business.
82240
The knee and ankle brace maker said it agreed to be bought by the medical device maker ReAble Therapeutics for about $1.6 billion including debt.
640611
Cambridge cancer drug maker Ariad Pharmaceuticals Inc. signed a major deal with Merck &amp; Co. Inc. yesterday in which the global pharmaceutical giant will pay $75 million to collaborate on developing and selling Ariad's experimental drug to treat sarcomas, a type of tumor that attacks fat, muscle, and bone.
517827
The drugmaker signed a deal to authorize a generic form of its osteoporosis drug Fosamax, which has annual sales of $3 billion, making it the worldâs top-selling drug for osteoporosis.
694626
Roche Holding AG  has agreed to  buy Ventana Medical Systems Inc  for $3.4 billion to  boost its diagnostics business, the Swiss drugmaker said on  Tuesday, raising its earlier bid.
841
Rockville biotech firm MacroGenics said yesterday that it has sold exclusive rights for its lead product in development -- a novel treatment for Type 1 diabetes -- to drug behemoth Eli Lilly for an initial payment of $41 million.
471781
The company is ready to handle competition from generics.
761145
Roche has received F.D.A. approval to market the first gene test that can help doctors reduce the risk of side effects for certain medications.
374108
Drug giant Novartis AG says it will give its Cambridge neighbor, MIT, $65 million over 10 years to create a research program, likely to be the biggest in the world aimed at revolutionizing the way drugs are made.
64992
Medarex Inc., a Princeton, NJ, biotechnology company, could receive up to $510 million under a global collaboration deal it signed with New York-based Pfizer Inc.
421804
Abbott Laboratories Inc. ABT.N is  betting $1 billion in deals and the start of a new clinical  trial will finally get Wall Street to focus on its  cardiovascular device business.
446395
The US government on Tuesday awarded Sanofi-Aventis (SASY.PA: Quote, Profile, Research) a contract worth up to $41 million through 2008 to ensure that enough eggs are available for future flu vaccine production.